Strategic Research on the Industrial Development of Innovative Technology in Cell Technology-Related Regenerative Medicine in China
Lu Shibi,Wu Zuze,Fu Xiaobing,Guo Quanyi,Cheng Jin,Zhao Shichong,Guo Weimin
DOI: https://doi.org/10.15302/j-sscae-2017.02.016
2017-01-01
Abstract:The innovative medical technology industry of regenerative medicine has shown huge economic potential and development prospects both at home and abroad in the last decade. After describing the current situation of industrial development in innovative technology in cell-technology-related regenerative medicine, we investigate, sort, and analyze related policies and regulations, management systems, and existing problems in the United States, the European Union, Japan, Australia, and other developed countries. On this basis, we study the current development situation, governmental regulation policies, and management mechanism of this industry in China. Next, we analyze and summarize the industry development trend, characteristics, and existing problems. Finally, based on experts’ advice and opinions on breaking through the bottleneck of industrial development, we suggest that it is imperative for us to strive to develop the innovative technology industry of cell-technology-related regenerative medicine in China.